{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:10Z","timestamp":1792791550179,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001391","name":"Whitehall Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA048336"],"award-info":[{"award-number":["DA048336"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA056547"],"award-info":[{"award-number":["DA056547"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA04319"],"award-info":[{"award-number":["DA04319"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111154","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:56:37Z","timestamp":1787759797000},"page":"111154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enhancement of 2-arachidonoylglycerol but not anandamide signaling in the ventral tegmental area selectively increases the choice to respond to reward-predictive incentive cues in male rats"],"prefix":"10.1016","volume":"301","author":[{"given":"Martin P.K.","family":"Leigh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3125-6349","authenticated-orcid":false,"given":"Jaqlyn","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Feja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-1885","authenticated-orcid":false,"given":"Gregory C.","family":"Loney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7518-572X","authenticated-orcid":false,"given":"Ken T.","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5856-6387","authenticated-orcid":false,"given":"Caroline E.","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111154_bib1","first-page":"119","article-title":"The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats","volume":"60","author":"Adamczyk","year":"2009","journal-title":"J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc."},{"key":"10.1016\/j.neuropharm.2026.111154_bib2","article-title":"The FAAH inhibitor URB597 reduces cocaine intake during conditioned punishment and mitigates cocaine seeking during withdrawal","volume":"165","author":"Alegre-Zurano","year":"2023","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.111154_bib3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41386-025-02245-6","article-title":"Cannabinoid CB1 receptor and mu-opioid receptor interaction: new insights from conditional knockout mice","volume":"51","author":"Alton","year":"2026","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2026.111154_bib4","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1523\/JNEUROSCI.1486-22.2023","article-title":"Decreased ventral tegmental area CB1R signaling reduces sign tracking and shifts cue-outcome dynamics in Rat Nucleus accumbens","volume":"43","author":"Bacharach","year":"2023","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1379889","article-title":"Cannabinoid type-1 receptor signaling in dopaminergic Engrailed-1 expressing neurons modulates motivation and depressive-like behavior","volume":"17","author":"Baddenhausen","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0091-3057(02)00945-0","article-title":"SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study","volume":"74","author":"Bass","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111154_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0376-8716(99)00150-7","article-title":"Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice","volume":"60","author":"Bass","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2026.111154_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2004.06.009","article-title":"Reversal of delta 9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors","volume":"496","author":"Bass","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0165-0173(98)00019-8","article-title":"What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?","volume":"28","author":"Berridge","year":"1998","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neuropharm.2026.111154_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coph.2008.12.014","article-title":"Dissecting components of reward:\u2018liking\u2019,\u2018wanting\u2019, and learning","volume":"9","author":"Berridge","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib11","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem Biol"},{"key":"10.1016\/j.neuropharm.2026.111154_bib12","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1096\/fj.13-247643","article-title":"Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity","volume":"28","author":"Boon","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.111154_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41386-018-0129-2","article-title":"Sex-dependent regulation of social reward by oxytocin: an inverted U hypothesis","volume":"44","author":"Borland","year":"2019","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2026.111154_bib14","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ijo.2009.138","article-title":"Obese adults have visual attention bias for food cue images: evidence for altered reward system function","volume":"33","author":"Castellanos","year":"2009","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neuropharm.2026.111154_bib15","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/bph.14976","article-title":"Attenuation of fear-conditioned analgesia in rats by monoacylglycerol lipase inhibition in the anterior cingulate cortex: potential role for CB2 receptors","volume":"177","author":"Corcoran","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib16","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1523\/JNEUROSCI.0285-21.2021","article-title":"Chronic augmentation of endocannabinoid levels persistently increases dopaminergic encoding of reward cost and motivation","volume":"41","author":"Covey","year":"2021","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2017.04.033","article-title":"Endocannabinoid modulation of dopamine neurotransmission","volume":"124","author":"Covey","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111154_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41398-025-03644-5","article-title":"Cannabinoid CB1 receptor in dopaminergic circuit from ventral tegmental area to nucleus accumbens links trait anxiety with reward learning","volume":"15","author":"Cui","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111154_bib19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0006-2952(93)90486-G","article-title":"Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist","volume":"46","author":"Deutsch","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.111154_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/jpet.123.001940","article-title":"Effects of repeated treatment with the monoacylglycerol lipase inhibitor MJN110 on pain-related depression of nesting and cannabinoid 1 receptor function in Male and female mice","volume":"390","author":"Diester","year":"2024","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111154_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108625","article-title":"Cocaine-induced increases in motivation require 2-arachidonoylglycerol mobilization and CB1 receptor activation in the ventral tegmental area","volume":"193","author":"Engi","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111154_bib23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.physbeh.2008.12.017","article-title":"Role of cannabinoid CB1 receptors on macronutrient selection and satiety in rats","volume":"96","author":"Escart\u00edn-P\u00e9rez","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2026.111154_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110031","article-title":"Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance","volume":"104","author":"Everett","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111154_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107814","article-title":"The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors","volume":"162","author":"Feja","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111154_bib26","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00213-016-4232-y","article-title":"Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats","volume":"233","author":"Forget","year":"2016","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2026.111154_bib27","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2026.111154_bib28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(97)01442-8","article-title":"Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors","volume":"341","author":"Gessa","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib30","article-title":"Endocannabinoid contributions to alcohol habits and motivation: relevance to treatment","author":"Gianessi","year":"2019","journal-title":"Addict. Biol. n\/a(n\/a"},{"key":"10.1016\/j.neuropharm.2026.111154_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173339","article-title":"Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands","volume":"213","author":"Ginsburg","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111154_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13293-022-00412-8","article-title":"Sex differences in sucrose reinforcement in Long-Evans rats","volume":"13","author":"Grimm","year":"2022","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.neuropharm.2026.111154_bib33","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.neuropharm.2026.111154_bib34","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1113\/jphysiol.2010.190066","article-title":"Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic\u2010AMP\/protein kinase A pathway in midbrain dopamine neurons","volume":"588","author":"Haj\u2010Dahmane","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1523\/JNEUROSCI.1493-22.2022","article-title":"Cannabinoid CB1 receptors are expressed in a subset of dopamine neurons and underlie cannabinoid-induced aversion, hypoactivity, and anxiolytic effects in mice","volume":"43","author":"Han","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/jpet.114.222315","article-title":"Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice","volume":"353","author":"Ignatowska-Jankowska","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111154_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2026.111154_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/neu.2014.3508","article-title":"Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury","volume":"32","author":"Katz","year":"2015","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neuropharm.2026.111154_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fnbeh.2020.00074","article-title":"Sex differences and the role of estradiol in mesolimbic reward circuits and vulnerability to cocaine and opiate addiction","volume":"14","author":"Kokane","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173649","article-title":"Melanin-concentrating hormone receptor antagonism differentially attenuates nicotine experience-dependent locomotor behavior in female and male rats","volume":"232","author":"Kuebler","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111154_bib41","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1097\/00001756-200409150-00028","article-title":"Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences","volume":"15","author":"Le Foll","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2026.111154_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.651272","article-title":"Monoacylglycerol lipase inhibitor MJN110 reduces neuronal hyperexcitability, restores dendritic arborization complexity, and regulates reward-related behavior in presence of HIV-1 tat","volume":"12","author":"League","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1374301","article-title":"A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation","volume":"15","author":"League","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib44","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0050-22.2022","article-title":"Sex differences in behavioral responding and dopamine release during pavlovian learning","volume":"9","author":"Lefner","year":"2022","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2026.111154_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1037\/bne0000132","article-title":"Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex interferes with anticipatory nausea in a rat model","volume":"130","author":"Limebeer","year":"2016","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib46","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0256-18.2018","article-title":"Nausea-induced 5-HT release in the interoceptive Insular cortex and regulation by Monoacylglycerol Lipase (MAGL) inhibition and cannabidiol","volume":"5","author":"Limebeer","year":"2018","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2026.111154_bib47","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1038\/s41467-023-43131-3","article-title":"Mobilization of endocannabinoids by midbrain dopamine neurons is required for the encoding of reward prediction","volume":"14","author":"Luj\u00e1n","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111154_bib48","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.neuropharm.2005.03.016","article-title":"Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction","volume":"48","author":"Lupica","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111154_bib50","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/npp.2015.351","article-title":"Differential control of cocaine self-administration by GABAergic and glutamatergic CB1 cannabinoid receptors","volume":"41","author":"Mart\u00edn-Garc\u00eda","year":"2016","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2026.111154_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq4779","article-title":"Elevating levels of the endocannabinoid 2-arachidonoylglycerol blunts opioid reward but not analgesia","volume":"10","author":"Mart\u00ednez-Rivera","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2026.111154_bib51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuropharm.2007.05.028","article-title":"Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area","volume":"54","author":"M\u00e1ty\u00e1s","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111154_bib52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1523\/JNEUROSCI.4503-03.2004","article-title":"Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral Tegmental area dopamine neurons through activation of CB1 receptors","volume":"24","author":"Melis","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1124\/jpet.108.138321","article-title":"The endogenous cannabinoid system modulates nicotine reward and dependence","volume":"326","author":"Merritt","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111154_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105729","article-title":"The endocannabinoidome in neuropsychiatry: opportunities and potential risks","volume":"170","author":"Morris","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2026.111154_bib56","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/cn400116z","article-title":"Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors","volume":"4","author":"Niphakis","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00213-006-0502-4","article-title":"Tonic dopamine: opportunity costs and the control of response vigor","volume":"191","author":"Niv","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2026.111154_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2014.03.017","article-title":"Endocannabinoid-mediated retrograde modulation of synaptic transmission","volume":"29","author":"Ohno-Shosaku","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib59","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.neuron.2011.11.018","article-title":"Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum","volume":"73","author":"Oleson","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111154_bib60","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012229","article-title":"A brain on cannabinoids: the role of dopamine release in reward seeking","volume":"2","author":"Oleson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuropharm.2026.111154_bib61","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.2042-7158.1973.tb10023.x","article-title":"Preparation of 9-tetrahydrocannabinol for intravenous injection","volume":"25","author":"Olsen","year":"1973","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib62","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1523\/JNEUROSCI.4033-07.2008","article-title":"Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons","volume":"28","author":"Pan","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib63","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrn4004","article-title":"Endocannabinoid signalling in reward and addiction","volume":"16","author":"Parsons","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib64","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/adb.12531","article-title":"Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine-induced dopamine release in the mouse nucleus accumbens","volume":"23","author":"Pavon","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib65","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00213-005-0195-0","article-title":"Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo","volume":"183","author":"Perra","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2026.111154_bib66","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2021.02.001","article-title":"Modulating the neuromodulators: dopamine, serotonin, and the endocannabinoid System","volume":"44","author":"Peters","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib67","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1523\/JNEUROSCI.3695-04.2004","article-title":"Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area","volume":"24","author":"Riegel","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib68","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","article-title":"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2026.111154_bib70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: an incentive-sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neuropharm.2026.111154_bib69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-psych-011624-024031","article-title":"The incentive-sensitization theory of addiction 30 years on","volume":"76","author":"Robinson","year":"2025","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib71","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuropharm.2019.05.031","article-title":"The ventral pallidum as a critical region for fatty acid amide hydrolase inhibition of nausea-induced conditioned gaping in male Sprague-Dawley rats","volume":"155","author":"Rock","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111154_bib72","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1089\/can.2022.0329","article-title":"The estrous cycle influences the effects of Fatty acid amide hydrolase and Monoacylglycerol lipase inhibition in the anxiety-like behavior in rats","volume":"9","author":"Salemme","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.neuropharm.2026.111154_bib73","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1124\/jpet.108.142224","article-title":"Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3\u2019-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats","volume":"327","author":"Scherma","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111154_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199549","article-title":"The endocannabinoid System in the development and treatment of obesity: searching for new ideas","volume":"26","author":"Serefko","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib75","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuropharm.2015.10.039","article-title":"Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex","volume":"102","author":"Sticht","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111154_bib76","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/adb.12573","article-title":"Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid expression of innate anxiety and excessive alcohol intake","volume":"23","author":"Stopponi","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib77","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1046\/j.1460-9568.2002.02041.x","article-title":"SHORT COMMUNICATION Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids","volume":"15","author":"Szabo","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib78","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbr.2018.11.023","article-title":"Sex differences in hedonic and homeostatic aspects of palatable food motivation","volume":"359","author":"Tapia","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111154_bib79","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1111\/bph.16197","article-title":"Sexually dimorphic effects of monoacylglycerol lipase inhibitor MJN110 on stress-related behaviour and drinking in Marchigian Sardinian alcohol-preferring rats","volume":"180","author":"Vozella","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2024.1363497","article-title":"Synthetic exendin-4 disrupts responding to reward predictive incentive cues in male rats","volume":"18","author":"Wakabayashi","year":"2024","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib82","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41386-018-0097-6","article-title":"Chemogenetic activation of ventral tegmental area GABA neurons, but not mesoaccumbal GABA terminals, disrupts responding to reward-predictive cues","volume":"44","author":"Wakabayashi","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111154_bib83","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.biopsych.2020.08.017","article-title":"Chemogenetic activation of mesoaccumbal gamma-aminobutyric acid projections selectively tunes responses to predictive cues when reward value is abruptly decreased","volume":"89","author":"Wakabayashi","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111154_bib84","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbr.2004.01.013","article-title":"Dissociation of the role of nucleus accumbens dopamine in responding to reward-predictive cues and waiting for reward","volume":"154","author":"Wakabayashi","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111154_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0361-9230(03)00081-9","article-title":"Neuromorphological background of cannabis addiction","volume":"61","author":"Wenger","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.111154_bib86","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.cub.2018.03.037","article-title":"Phasic dopamine signals in the nucleus accumbens that cause active avoidance require endocannabinoid mobilization in the midbrain","volume":"28","author":"Wenzel","year":"2018","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50112-5","article-title":"Cannabis Sativa targets mediobasal hypothalamic neurons to stimulate appetite","volume":"13","author":"Wheeler","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111154_bib88","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","article-title":"CB1 cannabinoid receptor-mediated modulation of food intake in mice","volume":"145","author":"Wiley","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111154_bib89","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1037\/bne0000201","article-title":"CB1 receptor antagonism in the bed nucleus of the stria terminalis interferes with affective opioid withdrawal in rats","volume":"131","author":"Wills","year":"2017","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib90","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1523\/JNEUROSCI.5282-03.2004","article-title":"The ventral tegmental area is required for the behavioral and nucleus accumbens neuronal firing responses to incentive cues","volume":"24","author":"Yun","year":"2004","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib91","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2026.111154_bib92","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/adb.12367","article-title":"Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats","volume":"22","author":"Zhang","year":"2017","journal-title":"Addict. Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:55:00Z","timestamp":1792788900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":91,"alternative-id":["S0028390826003291"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111154","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of 2-arachidonoylglycerol but not anandamide signaling in the ventral tegmental area selectively increases the choice to respond to reward-predictive incentive cues in male rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111154"}}